Publications

Please see the latest 20 publications as per JANUARY 2021

Congress Report: 5th Central and Eastern Europe (CEE) Summit on Osteoporosis in Bratislava, 2-3 December 2011.
Juraj Payer, John P Bilezikian, Gerold Holzer, Péter Lakatos, Olga Lesnyak, Roman Lorenc, Afrodite Zendeli, Heinrich Resch
Archives of Osteoporosis 12/2013; 8(1-2):123.

Epidemiology of proximal humeral fractures in Austria between 1989 and 2008.
H P Dimai, A Svedbom, A Fahrleitner-Pammer, T Pieber, H Resch, E Zwettler, H Thaler, M Szivak, K Amrein, F Borgström
Osteoporosis International 04/2013; · 4.58 Impact Factor

Computational identification and quantification of trabecular microarchitecture classes by 3-D texture analysis-based clustering.
Alexander Valentinitsch, Janina M Patsch, Andrew J Burghardt, Thomas M Link, Sharmila Majumdar, Lukas Fischer, Claudia Schueller-Weidekamm, Heinrich Resch, Franz Kainberger, Georg Langs
Bone 01/2013; · 4.02 Impact Factor

Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta.
Roland Kocijan, Christian Muschitz, Nadja Fratzl-Zelman, Judith Haschka, Hans-Peter Dimai, Angela Trubrich, Christina Bittighofer, Heinrich Resch
Skeletal Radiology 09/2012; · 1.54 Impact Factor 

Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density.
Christian Muschitz, Roland Kocijan, Astrid Fahrleitner-Pammer, Solveig Lung, Heinrich Resch
Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 07/2012;
· 6.04 Impact Factor

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study.
Bente Langdahl, Neil Binkley, Henry Bone, Nigel Gilchrist, Heinrich Resch, Jose Rodriguez Portales, Andrew Denker, Antonio Lombardi, Celine Le Bailly De Tilleghem, Carolyn Dasilva, Elizabeth Rosenberg, Albert Leung
Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 07/2012; 27(11):2251-8. · 6.04 Impact Factor

Update on denosumab in postmenopausal osteoporosis-recent clinical data.
Christian Muschitz, Astrid Fahrleitner-Pammer, Johannes Huber, Elisabeth Preisinger, Stefan Kudlacek, Heinrich Resch
Wiener Medizinische Wochenschrift 06/2012; 162(17-18):374-379.

Automated threshold-independent cortex segmentation by 3D-texture analysis of HR-pQCT scans.
Alexander Valentinitsch, Janina M Patsch, Julia Deutschmann, Claudia Schueller-Weidekamm, Heinrich Resch, Franz Kainberger, Georg Langs
Bone 06/2012; 51(3):480-7. · 4.02 Impact Factor

Österreichischer Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose: Addendum 2010
Hans Peter Dimai, Peter Pietschmann, Heinrich Resch, Elisabeth Preisinger, Astrid Fahrleitner-Pammer, Harald Dobnig, Klaus Klaushofer, on behalf of the Austrian Society for Bone and Mineral Research (AuSBMR
Wiener Medizinische Wochenschrift 05/2012; 160(21):586-589.

Österreichischer Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose – Update 2009
Hans Peter Dimai, Peter Pietschmann, Heinrich Resch, Elisabeth Preisinger, Astrid Fahrleitner-Pammer, Harald Dobnig, Klaus Klaushofer, für die Austrian Society for Bone and Mineral Research (AuSBMR
Wiener Medizinische Wochenschrift 04/2012; 159:1-34.

Management of osteoporosis in central and eastern Europe (CEE): conclusions of the “2nd Summit on Osteoporosis—CEE”, 21–22 November 2008, Warsaw, Poland
Roman S. Lorenc, Heinrich Resch, on behalf of the Members of the Summit on Osteoporosis—Central and Eastern Europe (CEE)”
Archives of Osteoporosis 04/2012; 4(1):1-8.

High-dose bisphoshonate therapy in an urgent case of spontaneous multiple vertebral fractures in a 55 year old woman
Christian Muschitz, Paul Roschger, Janina Patsch, Isabella Pollhammer, Bruno Koller, Klaus Klaushofer, Heinrich Resch
Wiener Medizinische Wochenschrift 04/2012; 157(15):388-391.

OPG-Fc treatment in growing pigs leads to rapid reductions in bone resorption markers, serum calcium, and bone formation markers.
W Sipos, P Zysset, P Kostenuik, E Mayrhofer, C Bogdan, M Rauner, M Stolina, D Dwyer, I Sommerfeld-Stur, G Pendl, H Resch, E Dall’Ara, P Varga, P Pietschmann
Hormone and Metabolic Research 12/2011; 43(13):944-9. · 2.19 Impact Factor

New considerations on the management of osteoporosis in Central and Eastern Europe (CEE):summary of the „3rd Summit on Osteoporosis-CEE“, November 2009, Budapest, Hungary.
Péter Lakatos, Adám Balogh, Edward Czerwinski, Hans P Dimai, Didier Hans, Gerold Holzer, Roman S Lorenc, Vladimir Palicka, Barbara Obermayer-Pietsch, Jan Stepan, István Takács, Heinrich Resch
Archives of Osteoporosis 12/2011; 6(1-2):1-12.

The 5-year follow-up of a cortical stress fracture resulting in a spontaneous atypical subtrochanteric femoral fracture in a female patient with severe osteoporosis and bisphosphonate therapy over 15 years.
Judith Haschka, Friederike Kühne, Christian Muschitz, Thomas Pirker, Roland Kocijan, Christina Bittighofer, Angela Trubrich, Heinrich Resch
Wiener klinische Wochenschrift 08/2011; 123(21-22):684-7. · 0.81 Impact Factor

Bone and cellular immune system of multiparous sows are insensitive to ovariectomy and nutritive calcium shortage.
W Sipos, E Kralicek, M Rauner, C J Duvigneau, H L Worliczek, D Schamall, R T Hartl, I Sommerfeld-Stur, E Dall’Ara, P Varga, H Resch, I Schwendenwein, P Zysset, P Pietschmann
Hormone and Metabolic Research 06/2011; 43(6):404-9. · 2.19 Impact Factor

Severe osteoporosis with multiple vertebral fractures after gender reassignment therapy – is it male or female osteoporosis?
Eva-Maria Fischer, Janina Patsch, Christian Muschitz, Stephan Becker, Heinrich Resch
Gynecological Endocrinology 05/2011; 27(5):341-4. · 1.58 Impact Factor

Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
Richard Eastell, Claus Christiansen, Andreas Grauer, Stepan Kutilek, Cesar Libanati, Michael R McClung, Ian R Reid, Heinrich Resch, Ethel Siris, Daniel Uebelhart, Andrea Wang, Georges Weryha, Steve R Cummings
Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 03/2011; 26(3):530-7. · 6.04 Impact Factor

Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect.
John A Eisman, Henry G Bone, David J Hosking, Michael R McClung, Ian R Reid, Rene Rizzoli, Heinrich Resch, Nadia Verbruggen, Carolyn M Hustad, Carolyn DaSilva, Romana Petrovic, Arthur C Santora, B Avery Ince, Antonio Lombardi
Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 02/2011; 26(2):242-51. · 6.04 Impact Factor

Trabecular bone microstructure and local gene expression in iliac crest biopsies of men with idiopathic osteoporosis.
Janina M Patsch, Thomas Kohler, Andrea Berzlanovich, Christian Muschitz, Christian Bieglmayr, Paul Roschger, Heinrich Resch, Peter Pietschmann
Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 02/2011; 26(7):1584-92. · 6.04 Impact Factor